Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

ABSTRACT: This study recruits patient with solid tumor types for sample collection and monitoring. Participants will provide blood and archival tissue samples in order to create a Personalized Cancer Monitoring (PCM) assay. This assay will be used to detect circulating tumor DNA (ctDNA) levels in the blood over time and hopefully contribute to improvements in residual disease detection methods for future patients. Results from this assay will be provided to participants and providers but providers are not asked to change patient care based on this information.

DISEASE(S): Solid Tumor,Colorectal Cancer,Non Small Cell Lung Cancer,Bladder Cancer,Cancer

PROVIDER: 2403134 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

MRD Screening Of Human B ALL

Project description:MRD screening in Human B-ALL: monitoring B-cell repertoires in longitudinal samples of patients.

2015-09-04 | E-ERAD-391 | biostudies-arrayexpress

A Transcriptome Fingerprinting Assay for Clinical Immune Monitoring

Project description:A Transcriptome Fingerprinting Assay for Clinical Immune Monitoring

| PRJNA390898 | ENA

Microfluidic platform for monitoring Saccharomyces cerevisiae mutation accumulation assay

Project description:Microfluidic platform for monitoring Saccharomyces cerevisiae mutation accumulation assay

| PRJEB43850 | ENA

Gene Expression Profiling of Formalin Fixed Paraffin Embedded Familial Breast Tumours Using the Whole Genome-DASL Assay

Project description:Tissue sample acquisition is a limiting step in many studies. There are many thousands of formalin fixed paraffin embedded archival blocks collected around the world, but in contrast relatively few fresh frozen samples in tumor banks. Once samples are fixed in formalin the RNA is degraded and traditional methods for gene expression profiling are not suitable. In this study we have evaluated the whole genome DASL assay from Illumina to perform transcriptomic analysis from archived breast tumor tissue fixed in formalin paraffin embedded blocks. We profiled 76 familial breast tumors from cases carrying a BRCA1, BRCA2 or ATM mutation, or from non-BRCA1/2 families. We found that replicate samples correlated well with each other (r2=0.9-0.98). In 12/15 cases, the matched formalin-fixed and frozen samples predicted the same tumor molecular subtypes with confidence. These results demonstrate that the whole genome DASL assay is a valuable tool to profile degraded RNA from archival FFPE material. This assay will enable transcriptomic analysis of a large number of archival samples that are stored in pathology archives around the globe and consequently will have the potential to improve our understanding and characterisation of many diseases. RNA was extracted from FFPE Familial breast tumours and analysed using the WG-DASL assay for Illumina.

2010-06-16 | E-GEOD-21921 | biostudies-arrayexpress

Gene Expression Profiling of Formalin Fixed Paraffin Embedded Familial Breast Tumours Using the Whole Genome-DASL Assay

2010-06-09 | GSE21921 | GEO

Kentucky assay

Project description:Kentucky assay

| PRJNA610532 | ENA

Multiplexed Identification of Cytotoxic Cell assay (PAINTKiller assay)

Project description:Multiplexed Identification of Cytotoxic Cell assay (PAINTKiller assay)

| PRJNA855945 | ENA

A Transcriptome Fingerprinting Assay for Clinical Immune Monitoring

Project description:Development of a cost-effective and practical targeted transcriptional fingerprinting assay (TFA) for monitoring a diverse repertoire of immune responses identified in the human blood transcriptome relying on a modular transcriptional repertoire built on the basis of variations in transcript abundance measured on a genome wide scale in the blood of nearly 1000 subjects across 16 immunologic conditions.

2020-06-16 | GSE100150 | GEO

Kentucky assay: Indole

Project description:Kentucky assay: Indole

| PRJNA610533 | ENA

Kentucky assay: undecanal

Project description:Kentucky assay: undecanal

| PRJNA509876 | ENA